Management of patients with upper gastrointestinal bleeding;Postȩpowanie u chorych z krwawieniem z górnego odcinka przewodu pokarmowego

Polski Przeglad Chirurgiczny

Volumn 79, Issue 1, 2007, Pages 89-102

  Wallner, Grzegorz ^a,b   Skoczylas, Tomasz ^a,b   Lundell, Lars ^c,d  

^a AM   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c Szpital Uniwersytetu Karolinska   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTON PUMP INHIBITOR;

BLEEDING; ENDOSCOPY; HUMAN; INCIDENCE; INTENSIVE CARE; MORTALITY; PH MEASUREMENT; RESUSCITATION; REVIEW; UPPER GASTROINTESTINAL BLEEDING;

EID: 33846015870     PISSN: 0032373X     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10035-007-0009-7     Document Type: Review

References (48)

1. Wilcox CM, Clark WS. Causes and outcome of upper and lower gastrointestinal bleeding: the Grady Hospital experience. South Med J 1999; 92: 44-50.
2. Yavorski RT, Wong RK, Maydonovitch C et al.: Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities. Am J Gastroenterol 1995; 90: 568-73.
3. Vreeburg EM, Snel P, de Bruijne JW et al.: Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol 1997; 92: 236-43.
4. Laine L, Peterson WL: Bleeding peptic ulcer. N Engl J Med 1994; 331: 717-27.
5. Forrest JAH, Finlayson NDC, Shearman DJC: Endoscopy in gastrointestinal bleeding. Lancet 1974; 2: 394-97.
6. Rockall TA, Logan RF, Devlin HB et al.: Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996; 38: 316-21.
7. Rockall TA, Logan RF, Devlin HB et al.: Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet 1996; 347: 1138-40.
8. British Society of Gastroenterology Endoscopy Committee. Non-variceal upper gastrointestinal haemorrhage: guidelines. Gut 2002; 51(Suppl IV): iv1-iv6.
9. Barkun A, Bardou M, Marshall JK: Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding. Ann Intern Med 2003; 139: 843-57.
10. American Society for Gastrointestinal Endoscopy. An Annotated Algorithmic Approach To Upper Gastrointestinal Bleeding. Gatrointest Endosc 2001; 53: 853-58.
11. American Society For Gastrointestinal Endoscopy. ASGE guideline: the role of endoscopy in acute non-variceal upper-GI hemorrhage. Gastrointest Endosc 2004; 60: 497-504.
12. Grenvick A, Ayres SM, Holbrook PR et al.: Textbook of critical care. Wyd. 4. Philadelphia, WB Saunders Company, 40-45.
13. Chak A, Cooper GS, Lloyd LE et al.: Effectiveness of endoscopy in patients admitted to the intensive care unit with upper GI hemorrhage. Gastrointest Endosc 2001; 53: 6-13.
14. Lin HJ, Wang K, Perng CL et al.: Early or delayed endoscopy for patients with peptic ulcer bleeding. A prospective randomized study. J Clin Gastroenterol 1996; 22: 267-71.
15. Lee JG, Turnipseed S, Romano PS et al.: Endoscopy-based triage significantly reduces hospitalization rates and costs of treating upper GI bleeding: a randomized controlled trial. Gastrointest Endosc 1999; 50: 755-61.
16. Longstreth GF, Feitelberg SP: Successful outpatient management of acute upper gastrointestinal hemorrhage: use of practice guidelines in a large patient series. Gastrointest Endosc 1998; 47: 219-22.
17. Bleau BL, Gostout CJ, Sherman KE et al.: Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointest Endosc 2002; 56: 1-6.
18. Cook DJ, Gayatt GH, Salena BJ et al.: Endoscopic therapy for acute non-variceal haemorrhage: a metaanalysis. Gastroenterology 1992; 102: 139-48.
19. Chung SCS, Leung JWC, Steele RJC: Endoscopic injection of adrenaline for actively bleeding ulcers; a randomised trial. BMJ 1988; 296: 1631-33.
20. Chung SCS, Leung JWC, Leough HT et al.: Adding a sclerosant to endoscopic epinphrine injection in actively bleeding ulcers: randomized trial. Gastrointest Endosc 1993; 39: 611-15.
21. Choudari CP, Palmer KR: Endoscopic injection therapy for bleeding peptic ulcer: a comparison of adrenaline alone with adrenaline plus ethanolamine oleate. Gut 1994; 35: 608-10.
22. Levy J, Khakoo S, Barton R et al.: Fatal injection sclerotherapy of a bleeding peptic ulcer. Lancet 1991; 337: 504.
23. Lazo MD, Andrade R, Medina MC et al.: Effect of injection sclerosis with alcohol on the rebleeding rate of gastroduodenal ulcers with unbleeding visible vessels; a prospective controlled trial. Am J Gastroneterol 1992; 87: 843-46.
24. Bardou M, Youssef M, Toubouti Y et al.: Newer endoscopic therapies decrease both re-bleeding and mortality in high risk patients with acute peptic ulcer bleeding: a series of meta-analyses [Abstract]. Gastroenterology 2003; 123: A239.
25. Bardou M, Toubouti Y, Benhaberou-Brun D et al.: High dose proton pump inhibition decrease both re-bleeding and mortality in high-risk patients with acute peptic ulcer bleeding. A series of meta-analyses [Abstract]. Gastroenterology 2003; 123: A625.
26. Lin HJ, Tseng GY, Perng CL et al.: Comparison of adrenaline injection and bipolar electrocoagulation for the arrest of peptic ulcer bleeding. Gut 1999; 44: 715-19.
27. Chung SS, Lau JY, Sung JJ et al.: Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcers. BMJ 1997; 314: 1307-11.
28. Tekant Y, Goh P, Alexander DJ et al.: Combination therapy using adrenaline and heater probe to reduce rebleeding in patients with peptic ulcer haemorrhage: a prospective randomized trial. Br J Surg 1995; 82: 223-26.
29. Chung IK, Ham JS, Kim HS et al.: Comparison of the hemostatic efficacy of the endoscopic hemoclip method with hypertonic saline- epinephrine injection and a combination of the two for the management of bleeding peptic ulcers. Gastrointest Endosc 1999; 49: 13-18.
30. Cipolletta L, Bianco MA, Marmo R et al.: Endoclips versus heater probe in preventing early recurrent bleeding from peptic ulcer: a prospective and randomized trial. Gastrointest Endosc 2001; 53: 147-51.
31. Gevers AM, De Goede E, Simoens M et al.: A randomized trial comparing injection therapy with hemoclip and with injection combined with hemoclip for bleeding ulcers. Gastrointest Endosc 2002; 55: 466-69.
32. Buffoli F, Graffeo M, Nicosia F et al.: Peptic ulcer bleeding: comparison of two hemostatic procedures. Am J Gastroenterol 2001; 96: 89-94.
33. Lanas A, Ferrandez A: NSAID- induced gastrointestinal damage: Current Clinical management and recommendations for prevention. Cin J Dig Dis 2006; 7: 127-33.
34. Peura DA: Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications. Am J Med 2004; 117 (Suppl 5A): 63S-71S.
35. Hawkey C, Talley NJ, Yeomans ND et al.: Improvement with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal anti-inflammatory drugs, including selective COX-2 inhibitors. Am J Gastroenterol 2005; 100: 1028-36.
36. Brett R: Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness. Critical Care 2005; 9: 45-50.
37. Garnett WR: History of acid suppression: focus on the hospital setting. Pharmacotherapy 2003; 23(10 Pt 2): 56S-60S.
38. Wallner G, Ciechański A, Wesołowski M et al.: Treatment of acute upper gastrointestinal bleeding with intravenous omeprazole or ranitidine. Eur J Clin Res 1996; 8: 235-43.
39. Levine JE, Leontiadis GI, Sharma VK et al.: Metaanalysis: the efficacy of intravenous H2-receptor antagonists in bleeding peptic ulcer. Aliment Pharmacol Ther 2002; 16: 1137-42.
40. Daneshmed TK, Hawkey CJ, Langman MJ et al.: Omeprazole versus placebo for acute upper gastrointestinal bleeding randomized controlled double trial. Br Med J 1992; 304: 143-14.
41. Lau JY, Sung JJ, Lee KK et al.: Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000; 343: 310-16.
42. Barkun A, Kennedy W, Herba K et al.: Prevention of peptic ulcer rebleeding using continuous infusion of pantoprazole vs ranitidine: a multicenter, multinational, randomized, double-blind, parallel-group comparison. Gastroenterology 2004; 126: A-78.
43. Martin RA et al.: Proton pump inhibitors versus H2-antagonists or placebo for gastrointestinal bleeding with or without endoscopic hemostasis. Gastroenterology 2003; 24 (Suppl 4); A625.
44. Rohss K et al.: Esomeprazole 40 mg administered intravenously provides better control of basal and stimulated gastric acid secretion than omeprazole 40 mg administered iv. Am J Gastroenterol 2004; 99: S12.
45. Rohss K et al.: Esomeprazole 40 mg IV raises intragastric pH to >4 more rapidly than pantoprazole 40 mg IV. Am J Gastroenterol 2004; 99: S2.
46. Hasselgren G, Keelan M, Kirdeikis P et al.: Optimization of acid suppression for patients with peptic ulcer bleeding: an intragastric pH-metry study with omeprazole. Eur J of Gastroenterol Hepatol 1998; 10: 601-06.
47. Barkun A, Fallone CA, Chiba N et al.: Nonvariceal Upper GI Bleeding Consensus Conference Group. Can J Gastroenterol 2004; 18: 605-09.
48. Bardou M, Barkun AN, Benhaberou-Brun D et al.: Metaanalysis; proton- pump inhibition in high-risk patients with acute peptic ulcer bleeding. Aliment Pharmacol Ther 2005; 21: 677-86.